{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-061057","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2025-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.295227+00:00","generated_at":"2026-05-18T09:40:54.563847+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Envoy Medical draws remaining $5M from GAT Funding; issues warrant for 750K shares at $1.48","bullets":["Drew $5M remaining principal under March 2025 note from GAT Funding, controlled by board member Glen Taylor.","Issued warrant for 750,000 shares of Class A common at $1.48/share closing price, exercisable for two years.","Warrant issued as commitment fee for draw; transaction is a related-party financing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-061057","json":"https://secwatch.observer/filing/0001213900-25-061057.json","markdown":"https://secwatch.observer/filing/0001213900-25-061057.md","text":"https://secwatch.observer/filing/0001213900-25-061057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025061057/0001213900-25-061057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025061057/ea0248067-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:40:54.563847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aa643dd415dbbbd61ed4f61306fa8b41cf2ff461","claim":"Envoy Medical, Inc. incurred loan of $5,000,000 with GAT Funding, LLC.","evidence_excerpt":"On June 26, 2025, Envoy Medical, Inc. (the “Company”) drew the remaining $5,000,000 of available principal under the promissory note, dated as of March 6, 2025 (the “Note”), between the Company and GAT Funding, LLC (“GAT”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390025061057/0001213900-25-061057-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$5,000,000"},{"label":"Counterparty","value":"GAT Funding, LLC"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}